Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study

被引:7
|
作者
Kim, Mihui [1 ]
Yang, Yong Sook [1 ]
Ko, Young-Guk [2 ]
Choi, Mona [3 ]
机构
[1] Yonsei Univ, Coll Nursing, Brain Korea 21 4 Project, Seoul 03722, South Korea
[2] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul 03722, South Korea
[3] Yonsei Univ, Mo Im Kim Nursing Res Inst, Coll Nursing, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
diabetes mellitus; exercise; major adverse cardiovascular event; major adverse limb event; peripheral artery disease; CHRONIC KIDNEY-DISEASE; PHYSICAL-ACTIVITY; RISK-FACTORS; ASSOCIATION; EPIDEMIOLOGY; MECHANISMS; EXERCISE; SYSTEM;
D O I
10.3390/jcm11092547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events. We aimed to investigate the associated factors of major adverse events in these patients. Materials and Methods: We conducted a retrospective longitudinal analysis using the electronic medical records from a tertiary hospital in Korea and included the data of 1263 patients. Eligible patients were categorized into four groups based on diabetes mellitus (DM) and regular exercise. The major adverse events included major adverse limb events and major adverse cardiovascular events. Major adverse events-free survival was assessed using the Kaplan-Meier method, and associated factors of major adverse events were analyzed using Cox proportional hazards analyses. Results: Kaplan-Meier survival curves showed that patients with DM and non-regular exercise had a shorter major adverse events-free survival. The Cox regression analysis showed that for patients with critical limb ischemia or chronic kidney disease, the risk of major adverse events increased, while group variables were not significant. Conclusion: Target management of patients with DM, critical limb ischemia, and chronic kidney disease is essential to reduce major adverse events after endovascular revascularization in patients with PAD.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Control of modifiable risk factors and major adverse cardiovascular events in people with peripheral artery disease and diabetes
    Golledge, Jonathan
    Drovandi, Aaron
    Rowbotham, Sophie
    Velu, Ramesh
    Quigley, Frank
    Jenkins, Jason
    WORLD JOURNAL OF DIABETES, 2021, 12 (06)
  • [32] Soft tissue reconstruction after revascularization in patients with peripheral artery disease
    Kampshoff, D.
    Kueckelhaus, M.
    Harati, K.
    Aitzetmueller, M.
    Hiort, M.
    Goetze, I.
    Hirsch, T.
    GEFASSCHIRURGIE, 2021, 26 (01): : 33 - 40
  • [33] Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease
    Cho, Sungsoo
    Lee, Yong-Joon
    Ko, Young-Guk
    Kang, Tae Soo
    Lim, Seong-Hoon
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (23) : 2359 - 2370
  • [34] Association of gout with major adverse cardiovascular events and all-cause mortality in patients with peripheral artery disease
    Singh, Tejas P.
    Wong, Shannon
    Quigley, Frank
    Jenkins, Jason
    Golledge, Jonathan
    ATHEROSCLEROSIS, 2020, 312 : 23 - 27
  • [35] Ultrasonography for the optimal selection of patients suitable for single session arteriography and endovascular revascularization in severe peripheral artery disease
    Spinu, Mihail
    Gligor, Rares Ioan
    Olinic, Maria
    Homorodean, Calin
    Ober, Mihai Claudiu
    Tataru, Dan
    Sabiescu, Bogdan
    Onea, Laurentiu
    Achim, Alexandru
    Lazar, Leontin
    Olinic, Dan Mircea
    MEDICAL ULTRASONOGRAPHY, 2024, 26 (04) : 376 - 382
  • [36] Sarcopenia is associated with lower step count in patients with peripheral artery disease following endovascular treatment
    Takino, Koya
    Hara, Yasutaka
    Sakui, Daisuke
    Kawamura, Itta
    Kikuchi, Jun
    Komoda, Takuyuki
    Koeda, Tomoko
    PHYSIOTHERAPY THEORY AND PRACTICE, 2025, 41 (01) : 222 - 229
  • [37] Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication
    Fashandi, Anna Z.
    Mehaffey, J. Hunter
    Hawkins, Robert B.
    Kron, Irving L.
    Upchurch, Gilbert R., Jr.
    Robinson, William P.
    JOURNAL OF VASCULAR SURGERY, 2018, 68 (06) : 1817 - 1823
  • [38] The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease
    Khoury, Hanane
    Lavoie, Louis
    Welner, Sharon
    Folkerts, Kerstin
    CARDIOVASCULAR THERAPEUTICS, 2016, 34 (02) : 115 - 124
  • [39] Major adverse events associated with inducible cardiac ischemia during treadmill exercise testing for peripheral artery disease
    Henkin, Stanislav
    McBane, Robert D.
    Rooke, Thom W.
    Wysokinski, Waldemar E.
    Casanegra, Ana, I
    Liedl, David A.
    Wennberg, Paul W.
    JOURNAL OF VASCULAR SURGERY, 2021, 74 (04) : 1335 - +
  • [40] The Impact of Ejection Fraction on Major Adverse Limb Events after Lower Extremity Revascularization
    Jamil, Yasser
    Huttler, Joshua
    Alameddine, Dana
    Wu, Zhen
    Zhuo, Haoran
    Mena-Hurtado, Carlos
    Velazquez, Eric J.
    Guzman, Raul J.
    Chaar, Cassius Iyad Ochoa
    ANNALS OF VASCULAR SURGERY, 2024, 98 : 210 - 219